Skip to content

Compression the analgesic effect of metoclopramide and ondansetron

Compression the analgesic effect of metoclopramide and ondansetron in renal colic

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130107012050N3
Enrollment
150
Registered
2020-06-01
Start date
2019-08-23
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Cholelithiasis

Interventions

Intervention 1: Intervention group 1: In this group 0.1 mg/kg intravenous morphine sulfate from Exir_Iran company and 0.075 mg/kg ondansetron from Tehran daru will be injected once. Intervention 2: I

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Diagnosis of renal stone by sonography Age between 18 to 55 years

Exclusion criteria

Exclusion criteria: Complicated renal stone such as pyelonephritis Oral or intravenous drug administration in 6 hours before refer to hospital Addiction Pregnancy Chronic renal or liver disease Bilateral stone Drug allergy

Design outcomes

Primary

MeasureTime frame
Pain control. Timepoint: On arrival, 15 minutes, 30 minutes, 1 and 2 hours after drug administration. Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Nausea control. Timepoint: On arrival, 15 minutes, 30 minutes, 1 and 2 hours after drug administration. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Ali Jafari Nodoshan

Yazd University of Medical Sciences

malijafari@ssu.ac.ir+98 913 358 9274

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026